Home › Funds › PRELUDE CAPITAL MANAGEMENT, LLC › TECH

PRELUDE CAPITAL MANAGEMENT, LLC position in TECH

BIO-TECHNE CORP · Health Care

PRELUDE CAPITAL MANAGEMENT, LLC reported holding 91,696 shares of TECH (BIO-TECHNE CORP) in its Q2 2026 13F filing — a position valued at US$6.5M, representing 0.52% of its reported portfolio and ranking #28 among its reported holdings. PRELUDE CAPITAL MANAGEMENT, LLC has disclosed TECH holdings in 7 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)91.70K sh
Reported value held$6.48M
Portfolio Weight0.52%
First reportedQ3 2023
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PRELUDE CAPITAL MANAGEMENT, LLC's TECH position evolved

PRELUDE CAPITAL MANAGEMENT, LLC first disclosed a stake in TECH in Q3 2023 at 6,791 shares (US$462K). The position peaked in Q2 2026 at 91,696 shares, worth US$6.5M. Across 7 filings, PRELUDE CAPITAL MANAGEMENT, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 91,696 shares valued at US$6.5M. Notable position changes include a 68% increase in Q4 2023 (shares fell 9% over the following quarter), a 127% increase in Q1 2024 (shares rose 2% over the following quarter), a 82% trim in Q3 2024 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 6.79K $462.26K New
Q4 2023 11.39K $879.16K Add
Q1 2024 25.88K $1.82M Add
Q2 2024 19.32K $1.38M Reduce
Q3 2024 3.51K $280.71K Reduce
Q2 2025 9.53K $490.32K New
Q2 2026 91.70K $6.48M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TECH and 13F data

TECH (BIO-TECHNE CORP) is a Health Care company. 29 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$482.2M), Ruane Cunniff & Goldfarb (Sequoia) (US$236.6M), SNYDER CAPITAL MANAGEMENT L P (US$223.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TECH

All TECH fund holders →

FAQ

How long has PRELUDE CAPITAL MANAGEMENT, LLC held TECH?

PRELUDE CAPITAL MANAGEMENT, LLC has disclosed TECH holdings in 7 of the last 12 reported quarters, going back to Q3 2023.

What is PRELUDE CAPITAL MANAGEMENT, LLC's current position in TECH?

As of Q2 2026, PRELUDE CAPITAL MANAGEMENT, LLC holds 91.70K shares of TECH (BIO-TECHNE CORP), valued at $6.48M, representing 0.52% of its reported portfolio and ranking #28.

Has PRELUDE CAPITAL MANAGEMENT, LLC been buying or selling TECH?

In the latest 13F filing (Q2 2026), PRELUDE CAPITAL MANAGEMENT, LLC newly opened its position in TECH. The position peaked in Q2 2026 at 91.70K shares.

Which other funds hold TECH?

Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), SNYDER CAPITAL MANAGEMENT L P, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.